Estimated Long-Term Survival With Eplerenone

J Am Coll Cardiol. 2019 May 14;73(18):2357-2359. doi: 10.1016/j.jacc.2019.02.043.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Eplerenone / therapeutic use*
  • Female
  • Health Services Misuse / statistics & numerical data*
  • Heart Failure* / drug therapy
  • Heart Failure* / mortality
  • Heart Failure* / physiopathology
  • Humans
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Mineralocorticoid Receptor Antagonists / therapeutic use
  • Myocardial Infarction* / drug therapy
  • Myocardial Infarction* / physiopathology
  • Randomized Controlled Trials as Topic
  • Stroke Volume / drug effects
  • Time
  • Ventricular Dysfunction, Left / diagnosis
  • Ventricular Dysfunction, Left / etiology

Substances

  • Mineralocorticoid Receptor Antagonists
  • Eplerenone

Associated data

  • ClinicalTrials.gov/NCT00232180